"CD13 Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Zinc-binding metalloproteases that are members of the type II integral membrane metalloproteases. They are expressed by GRANULOCYTES; MONOCYTES; and their precursors as well as by various non-hematopoietic cells. They release an N-terminal amino acid from a peptide, amide or arylamide.
| Descriptor ID |
D018826
|
| MeSH Number(s) |
D08.811.277.656.350.100.160 D08.811.277.656.350.555.100 D08.811.277.656.675.555.100 D23.050.301.264.894.113 D23.101.100.894.113
|
| Concept/Terms |
CD13 Antigens- CD13 Antigens
- CD13 Antigen
- Antigen, CD13
- Aminopeptidase M
- Alanyl Aminopeptidase
- Aminopeptidase N
- Membrane Alanyl Aminopeptidase
- Alanine Aminopeptidase
- Antigens, CD13
|
Below are MeSH descriptors whose meaning is more general than "CD13 Antigens".
Below are MeSH descriptors whose meaning is more specific than "CD13 Antigens".
This graph shows the total number of publications written about "CD13 Antigens" by people in this website by year, and whether "CD13 Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 1 | 2 |
| 2010 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "CD13 Antigens" by people in Profiles.
-
Ferreri AJM, Calimeri T, Conte GM, Cattaneo D, Fallanca F, Ponzoni M, Scarano E, Curnis F, Nonis A, Lopedote P, Citterio G, Politi LS, Foppoli M, Girlanda S, Sassone M, Perrone S, Cecchetti C, Ciceri F, Bordignon C, Corti A, Anzalone N. R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-a in primary CNS lymphoma. Blood. 2019 07 18; 134(3):252-262.
-
Haraguchi N, Ishii H, Mimori K, Tanaka F, Ohkuma M, Kim HM, Akita H, Takiuchi D, Hatano H, Nagano H, Barnard GF, Doki Y, Mori M. CD13 is a therapeutic target in human liver cancer stem cells. J Clin Invest. 2010 Sep; 120(9):3326-39.
-
Loftus JP, Williams JM, Belknap JK, Black SJ. In vivo priming and ex vivo activation of equine neutrophils in black walnut extract-induced equine laminitis is not attenuated by systemic lidocaine administration. Vet Immunol Immunopathol. 2010 Nov 15; 138(1-2):60-9.
-
Black SJ, Lunn DP, Yin C, Hwang M, Lenz SD, Belknap JK. Leukocyte emigration in the early stages of laminitis. Vet Immunol Immunopathol. 2006 Jan 15; 109(1-2):161-6.
-
Potolicchio I, Carven GJ, Xu X, Stipp C, Riese RJ, Stern LJ, Santambrogio L. Proteomic analysis of microglia-derived exosomes: metabolic role of the aminopeptidase CD13 in neuropeptide catabolism. J Immunol. 2005 Aug 15; 175(4):2237-43.